Citing Article List

The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data”.

No.

Publication Date

Citing Article

1

2025

Samaneh Boroomand, Delara Mohammad-Aghaie, Fatemeh Mohammadpour. Deep eutectic solvents: A strategy for boosting alprazolam solubility and permeability in an intestinal membrane model, Journal of Molecular Liquids. 2025; 438: 128708128708.  https://doi.org/10.1016/j.molliq.2025.128708

2

2026

Chin Hang Yiu, Kevin Winardi, Christine Y. Lu. Immunological Drug–Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence, Current Oncology Reports. 2026; 28: 51.  https://doi.org/10.1007/s11912-026-01789-0

3

2026

Mostafa Seblani, Serge Yaacoub, Patrick J. Hanley, Dalia Haydar. Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?, Cytotherapy. 2026; 102913102913.  https://doi.org/10.1016/j.jcyt.2026.102913

4

2025

Heather Derry‐Vick, Neil J. Shah, Jaeil Ahn, Bianca DeAgresta, Alexandra Della Pia, Jacob P. Zaemes, Lauren Pascual, Natalie Arias‐Orozco, Rachel Zemel, George Sidarous, Michael Serzan, Shaked Lev‐Ari, Adil Alaoui, Alex Marki, Kenna Nguyen, Charalampos Charalampous, Iris Rahman, Olivia Wilkins, Marina Girgis, Aishwarya Sridhar, David Adams, Andrew L. Pecora, Michael B. Atkins, Andrew Ip. Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes, Cancer Medicine. 2025; 14: e71326.  https://doi.org/10.1002/cam4.71326